These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19378203)

  • 1. Transplantation of oligodendrocyte progenitor cells in animal models of leukodystrophies.
    Kondo Y; Duncan ID
    Methods Mol Biol; 2009; 549():175-85. PubMed ID: 19378203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation of high-purity oligodendroglial progenitors.
    Hatch MN; Nistor G; Keirstead HS
    Methods Mol Biol; 2009; 549():59-75. PubMed ID: 19378196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of cultured oligodendrocyte progenitor cells from rat neonatal brains.
    Larsen EC; Kondo Y; Fahrenholtz CD; Duncan ID
    Curr Protoc Stem Cell Biol; 2008 Aug; Chapter 2():Unit 2D.1.1-2D.1.13. PubMed ID: 18729048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligodendrocyte-spinal cord explant co-culture: an in vitro model for the study of myelination.
    Chen Z; Ma Z; Wang Y; Li Y; Lü H; Fu S; Hang Q; Lu PH
    Brain Res; 2010 Jan; 1309():9-18. PubMed ID: 19879858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplanted neural stem/progenitor cells generate myelinating oligodendrocytes and Schwann cells in spinal cord demyelination and dysmyelination.
    Mothe AJ; Tator CH
    Exp Neurol; 2008 Sep; 213(1):176-90. PubMed ID: 18586031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic resistance of neural stem cells to toxic metabolites may make them well suited for cell non-autonomous disorders: evidence from a mouse model of Krabbe leukodystrophy.
    Taylor RM; Lee JP; Palacino JJ; Bower KA; Li J; Vanier MT; Wenger DA; Sidman RL; Snyder EY
    J Neurochem; 2006 Jun; 97(6):1585-99. PubMed ID: 16805770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and characterization of oligodendrocytes from lineage-selectable embryonic stem cells in vitro.
    Billon N; Jolicoeur C; Raff M
    Methods Mol Biol; 2006; 330():15-32. PubMed ID: 16846014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of oligodendrocyte progenitor cells from dissociated monolayer and feeder-free cultured pluripotent stem cells.
    Yamashita T; Miyamoto Y; Bando Y; Ono T; Kobayashi S; Doi A; Araki T; Kato Y; Shirakawa T; Suzuki Y; Yamauchi J; Yoshida S; Sato N
    PLoS One; 2017; 12(2):e0171947. PubMed ID: 28192470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and culture of rat and mouse oligodendrocyte precursor cells.
    Chen Y; Balasubramaniyan V; Peng J; Hurlock EC; Tallquist M; Li J; Lu QR
    Nat Protoc; 2007; 2(5):1044-51. PubMed ID: 17546009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplanted human embryonic germ cell-derived neural stem cells replace neurons and oligodendrocytes in the forebrain of neonatal mice with excitotoxic brain damage.
    Mueller D; Shamblott MJ; Fox HE; Gearhart JD; Martin LJ
    J Neurosci Res; 2005 Dec; 82(5):592-608. PubMed ID: 16247803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haplotype matching is not an essential requirement to achieve remyelination of demyelinating CNS lesions.
    Tepavcević V; Blakemore WF
    Glia; 2006 Dec; 54(8):880-90. PubMed ID: 17006890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to make an oligodendrocyte.
    Goldman SA; Kuypers NJ
    Development; 2015 Dec; 142(23):3983-95. PubMed ID: 26628089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimally manipulated oligodendrocyte precursor cells retain exclusive commitment to the oligodendrocyte lineage following transplantation into intact and injured hippocampus.
    Webber DJ; Compston A; Chandran S
    Eur J Neurosci; 2007 Oct; 26(7):1791-800. PubMed ID: 17897393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of oligodendrocyte lineage precursor cells in the mouse cerebral cortex: a confocal microscopy approach to demyelinating diseases.
    Girolamo F; Strippoli M; Errede M; Benagiano V; Roncali L; Ambrosi G; Virgintino D
    Ital J Anat Embryol; 2010; 115(1-2):95-102. PubMed ID: 21072997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligodendrocytes and the "micro brake" of progenitor cell proliferation.
    Nave KA
    Neuron; 2010 Mar; 65(5):577-9. PubMed ID: 20223193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Directed Differentiation of Oligodendrocyte Progenitor Cells From Mouse Induced Pluripotent Stem Cells.
    Terzic D; Maxon JR; Krevitt L; DiBartolomeo C; Goyal T; Low WC; Dutton JR; Parr AM
    Cell Transplant; 2016; 25(2):411-24. PubMed ID: 25955415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of induced pluripotent stem cells into functional oligodendrocytes.
    Czepiel M; Balasubramaniyan V; Schaafsma W; Stancic M; Mikkers H; Huisman C; Boddeke E; Copray S
    Glia; 2011 Jun; 59(6):882-92. PubMed ID: 21438010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells.
    Najm FJ; Lager AM; Zaremba A; Wyatt K; Caprariello AV; Factor DC; Karl RT; Maeda T; Miller RH; Tesar PJ
    Nat Biotechnol; 2013 May; 31(5):426-33. PubMed ID: 23584611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H-ferritin is the major source of iron for oligodendrocytes.
    Todorich B; Zhang X; Connor JR
    Glia; 2011 Jun; 59(6):927-35. PubMed ID: 21446040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glial progenitor-based repair of demyelinating neurological diseases.
    Keyoung HM; Goldman SA
    Neurosurg Clin N Am; 2007 Jan; 18(1):93-104, x. PubMed ID: 17244557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.